RXST

RxSight Inc

4.87

Oct 30 • 3:59 PM ET -0.18 (-3.56%)

4.75

Aftermarket • 7:59 PM ET -0.12 (-2.52%)

Healthcare Medical Devices USA Micro NASD

Peers: LNSR ALC STAA BLCO SGHT GKOS COO HROW INMD EYPT

| Held by: VTI IWM VXF IWN VTWO SCHA IWC VHT PRFZ BUSM

Scroll to Statements

Index	RUT
Market Cap	202.56M
Enterprise Value	4.34M
Income	-46.95M
Sales	127.58M
Book/sh	6.33
Cash/sh	5.02
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	461
IPO	Jul 30, 2021

P/E	-
Forward P/E	-
PEG	-
P/S	1.59
P/B	0.77
P/C	0.97
P/FCF	-
EV/EBITDA	-
EV/Sales	0.03
Quick Ratio	3.61
Current Ratio	4.07
Debt/Eq	0.04
LT Debt/Eq	0.03
Option/Short	Yes / Yes

EPS (ttm)	-1.14
EPS next Y	-1.16
EPS next Q	-0.31
EPS this Y	0.66%
EPS next Y	-23.42%
EPS next 5Y	10.81%
EPS past 3/5Y	26.63% -
Sales past 3/5Y	40.00% 55.74%
EPS Y/Y TTM	-42.62%
Sales Y/Y TTM	-13.24%
EPS Q/Q	-0.80%
Sales Q/Q	0.31%
Earnings	Nov 03 AMC
EPS/Sales Surpr.	11.96% 3.66%

Insider Own	7.24%
Insider Trans	-0.56%
Inst Own	103.53%
Inst Trans	-0.90%
ROA	-14.19%
ROE	-17.35%
ROIC	-17.24%
Gross Margin	77.50%
Oper. Margin	-43.20%
Profit Margin	-36.80%
SMA20	1.48%
SMA50	-9.71%
SMA200	-23.49%
Trades

Shs Outstand	41.59M
Shs Float	38.58M
Short Float	10.68%
Short Ratio	5.28
Short Interest	4.12M
52W High	13.22 -63.16%
52W Low	4.40 10.68%
Volatility	4.37% 4.97%
ATR (14)	0.25
RSI (14)	46.56
Beta	1.21
Rel Volume	0.60
Avg Volume	780.78K
Volume	468,496

Perf Week	-2.99%
Perf Month	2.53%
Perf Quarter	-22.58%
Perf Half Y	-34.19%
Perf YTD	-53.26%
Perf Year	-43.31%
Perf 3Y	-76.71%
Perf 5Y	-59.35%
Perf 10Y	-
Recom	3.10
Target Price	7.57
Prev Close	5.05
Price	4.87
Change %	-3.56%

Consensus

Hold

Avg. Price Target

$7.57

Implied Upside

+55.4%

Analysts12incl. previous ratings

Rating Distribution1 Buy · 9 Hold · 2 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Jan 30, 2026	Initiated	WWilliam Blair	Mkt Perform
Jul 15, 2025	Downgrade	MMorgan Stanley	Overweight → Equal-Weight	$9	+84.8%
Jul 10, 2025	Downgrade	JJefferies	Buy → Hold	$9	+84.8%
Jul 09, 2025	Downgrade	WWells Fargo	Overweight → Equal Weight	$9	+84.8%
Jul 09, 2025	Downgrade	OOppenheimer	Outperform → Perform
Jul 09, 2025	Downgrade	BBTIG Research	Buy → Neutral
May 19, 2025	Upgrade	WWells Fargo	Equal Weight → Overweight	$25	+413.3%
Apr 15, 2025	Initiated	PPiper Sandler	Neutral	$18	+269.6%
Apr 09, 2025	Downgrade	UUBS	Buy → Neutral	$16	+228.5%
Apr 04, 2025	Downgrade	JJP Morgan	Overweight → Underweight	$40 → $17	+249.1%
Apr 03, 2025	Downgrade	BBofA Securities	Buy → Underperform	$36 → $22	+351.7%
Dec 20, 2024	Downgrade	SStifel	Buy → Hold	$65 → $40	+721.4%
Dec 11, 2024	Downgrade	WWells Fargo	Overweight → Equal Weight	$56 → $42	+762.4%
Dec 06, 2024	Initiated	UUBS	Buy	$52	+967.8%
Oct 29, 2024	Initiated	JJefferies	Buy	$72	+1,378.4%
Aug 20, 2024	Reiterated	NNeedham	Buy	$54 → $66	+1,255.2%
Aug 06, 2024	Reiterated	NNeedham	Buy	$75 → $54	+1,008.8%
May 07, 2024	Reiterated	BBTIG Research	Buy	$61 → $72	+1,378.4%
Dec 13, 2023	Upgrade	WWells Fargo	Equal Weight → Overweight	$31 → $42	+762.4%
Dec 12, 2023	Initiated	SStifel	Buy	$40	+721.4%

Oct-26-26 10:49PM	RxSight Heads Into Third Quarter With Wall Street Bracing For Shrinking Sales And Wider Losses (Earnings Whispers)
Oct-23-26 08:00PM	RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules (GlobeNewswire)
Oct-20-26 04:05PM	RxSight, Inc. to Report Third Quarter 2026 Financial Results on November 3 (GlobeNewswire)
Oct-19-26 09:00AM	RxSight Appoints Eye Care Industry Leaders to Drive Commercial Transformation (GlobeNewswire)
Aug-26-26 04:15PM	RxSight, Inc. to Participate in the Wells Fargo Healthcare Conference (GlobeNewswire)
09:21AM	Loading…
Aug-06-26 09:21AM	Earnings To Watch: RxSight Inc (RXST) Q2 2026 -- GF Value Sees 519% Upside (GuruFocus.com)
01:10AM	RxSight Inc (RXST) (Q2 2026) Earnings Call Highlights: Strategic Pivot Amid Revenue Decline and ... (GuruFocus.com)
Aug-05-26 04:05PM	RxSight, Inc. Reports Second Quarter 2026 Results and Provides Update on 2026 Outlook (GlobeNewswire)
Jul-26-26 04:00PM	RxSight Reports Inducement Grants as Permitted by the Nasdaq Listing Rules (GlobeNewswire)
Jul-15-26 04:15PM	RxSight Announces Appointments of Aziz Mottiwala as Chief Executive Officer and Ron Kurtz, M.D. as Chief Medical Officer (GlobeNewswire) +6.71% +6.10%
Jul-06-26 04:15PM	RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement (GlobeNewswire)
04:15PM	Alcon and RxSight Announce Collaboration to Develop Adjustable PCIOLs (GlobeNewswire)
Jul-02-26 03:02PM	Did RxSight, Inc. Insiders Breach their Fiduciary Duties to Shareholders? (PR Newswire) +8.51%
May-19-26 04:10PM	RxSight, Inc. to Present at the Stifel 2026 Virtual Ophthalmology Forum (GlobeNewswire)
May-06-26 04:05PM	RxSight, Inc. Reports First Quarter 2026 Results and Reiterates Full-Year Sales Outlook (GlobeNewswire) -6.61% -14.45%
04:10PM	Loading…
Apr-29-26 04:10PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire) -5.02%
Apr-22-26 04:10PM	RxSight, Inc. to Report First Quarter 2026 Financial Results on May 6 (GlobeNewswire)
Apr-08-26 04:05PM	RxSight Highlights 300,000 Light Adjustable Lens Implant Milestone and Strong Scientific Presence at ASCRS 2026 (GlobeNewswire) +7.69% -7.01%
Apr-02-26 04:10PM	RxSight, Inc. to Participate in the 25th Annual Needham Virtual Healthcare Conference (GlobeNewswire) +5.72%
Feb-26-26 02:11AM	RxSight Q4 Earnings Call Highlights (MarketBeat) -10.10%
12:05AM	RxSight Inc (RXST) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... (GuruFocus.com)
Feb-25-26 07:25PM	RxSight, Inc. (RXST) Reports Q4 Loss, Beats Revenue Estimates (Zacks)
04:05PM	RXSight, Inc. Reports Fourth Quarter and 2025 Results; Issues 2026 Guidance (GlobeNewswire)
Feb-24-26 07:30PM	Alphatec (ATEC) Q4 Earnings and Revenues Beat Estimates (Zacks)
07:30AM	Earnings To Watch: RxSight Inc (RXST) Reports Q4 2025 Result (GuruFocus.com)
Feb-19-26 10:00AM	Earnings Preview: Teleflex (TFX) Q4 Earnings Expected to Decline (Zacks)
Feb-18-26 10:00AM	Earnings Preview: RxSight, Inc. (RXST) Q4 Earnings Expected to Decline (Zacks)
Feb-11-26 04:10PM	RxSight, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 (GlobeNewswire)
03:15PM	RxSight, Inc. (RXST) Initiated at Market Perform as Firm Seeks Sales Reacceleration (Insider Monkey)
Jan-30-26 09:54AM	Spotify upgraded, Pinterest downgraded: Wall Street's top analyst calls (The Fly)
06:16AM	Loading…
Jan-13-26 06:16AM	RxSight (RXST) Soars 14.1%: Is Further Upside Left in the Stock? (Zacks)
Jan-11-26 09:30AM	RxSight, Inc. Announces Preliminary Q4 and 2025 Financial Results; New Chief Financial Officer (GlobeNewswire)
Jan-02-26 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-23-25 12:42PM	RxSight CFO exit raises concerns over pace of recovery, BTIG says (Investing.com) -9.98%
Dec-22-25 05:15PM	RxSight, Inc. Announces Chief Financial Officer Transition (GlobeNewswire)
Nov-20-25 04:05PM	RxSight, Inc. to Present at the Piper Sandler Healthcare Conference (GlobeNewswire) -5.79% +13.41%
Nov-06-25 12:04AM	RxSight Inc (RXST) Q3 2025 Earnings Call Highlights: Navigating Growth Amid Revenue Challenges (GuruFocus.com)
Nov-05-25 06:50PM	RxSight, Inc. (RXST) Reports Q3 Loss, Tops Revenue Estimates (Zacks) -7.33%
04:05PM	RxSight, Inc. Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-04-25 08:31AM	RxSight Inc (RXST) Q3 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-22-25 04:05PM	RxSight, Inc. to Report Third Quarter 2025 Financial Results on November 5, 2025 (GlobeNewswire)
Oct-16-25 04:05PM	RxSight, Inc. to Feature Live Learning Sessions at American Academy of Ophthalmology 2025 Annual Meeting (GlobeNewswire) +7.34%
Sep-16-25 08:45AM	Investors in RxSight, Inc. Should Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST (PR Newswire)
Sep-15-25 09:32AM	RxSight (RXST) Fell Due to Missed Expectations and Guidance Reduction (Insider Monkey)
Sep-09-25 09:00AM	RxSight, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST (PR Newswire) +9.40%
Sep-05-25 04:09PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
Sep-04-25 03:59PM	Investors Urged to Contact Levi & Korsinsky for Information Before September 22, 2025 - RxSight, Inc. (RXST) (Newsfile)
Aug-25-25 04:05PM	RxSight, Inc. to Present at the Morgan Stanley Healthcare Conference (GlobeNewswire) -7.22%
Aug-22-25 08:45AM	RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST (PR Newswire) +6.30%
Aug-14-25 04:05PM	RxSight, Inc. to Present at the Wells Fargo Healthcare Conference (GlobeNewswire)
Aug-13-25 05:14PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile) +13.06%
Aug-12-25 09:00AM	RxSight, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - RXST (PR Newswire) +10.53%
Aug-07-25 06:15PM	RxSight, Inc. (RXST) Reports Q2 Loss, Beats Revenue Estimates (Zacks) -7.70%
04:05PM	RxSight, Inc. Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-04-25 08:05AM	RxSight, Inc. Appoints Raymond W. Cohen to Its Board of Directors (GlobeNewswire)
Aug-01-25 09:00AM	RxSight, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before September 22, 2025 to Discuss Your Rights - RXST (PR Newswire)
Jul-31-25 04:15PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
Jul-30-25 04:02PM	Investors in RxSight, Inc. (RXST): Protect Your Rights - Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
Jul-25-25 04:54PM	RxSight, Inc. (RXST) Lawsuit - Investors Urged to Contact Levi & Korsinsky Before September 22, 2025 (Newsfile)
Jul-24-25 04:05PM	RxSight, Inc. to Report Second Quarter 2025 Financial Results on August 7, 2025 (GlobeNewswire)
Jul-09-25 03:00AM	RxSight Inc (RXST) Q2 2025 Earnings Call Highlights: Strategic Shifts Amid Market Challenges (GuruFocus.com) -37.84%
Jul-08-25 04:05PM	RxSight, Inc. Announces Preliminary Second Quarter 2025 Revenue and Revised 2025 Guidance (GlobeNewswire)
Jul-04-25 11:40AM	FMS vs. RXST: Which Stock Is the Better Value Option? (Zacks)
Jun-18-25 11:40AM	KMDA vs. ACAD: Which Stock Is the Better Value Option? (Zacks)
11:40AM	FMS or RXST: Which Is the Better Value Stock Right Now? (Zacks)
May-31-25 05:59AM	Down Over 30%: Wells Fargo Says Now Is the Time to Load Up on These 2 Beaten-Down Stocks (TipRanks)
May-23-25 08:32AM	Do Options Traders Know Something About RxSight Stock We Don't? (Zacks)
May-20-25 04:10PM	RxSight, Inc. to Participate in the Stifel 2025 Virtual Ophthalmology Forum (GlobeNewswire)
10:55AM	Wells Fargo Upgrades RxSight (RXST), Sees LAL Technology as Undervalued (Insider Monkey)
May-08-25 03:31AM	RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances Amid ... (GuruFocus.com) -11.21%
May-07-25 11:04PM	RxSight, Inc. (RXST) Q1 2025 Earnings Call Transcript (Seeking Alpha) +6.81%
07:55PM	RxSight, Inc. (RXST) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	RxSight, Inc. Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-01-25 10:01AM	CVRx (CVRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-30-25 04:05PM	RxSight, Inc. to Present at the Bank of America Healthcare Conference (GlobeNewswire)
10:01AM	RxSight, Inc. (RXST) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Apr-23-25 04:05PM	RxSight, Inc. to Report First Quarter 2025 Financial Results on May 7, 2025 (GlobeNewswire)
Apr-04-25 11:46AM	JP Morgan downgrades RxSight on market, competitive pressures (Investing.com)
09:40AM	Block upgraded, Nvidia downgraded: Wall Streets top analyst calls (TipRanks)
03:00AM	RxSight Inc (RXST) Q1 2025 Earnings Call Highlights: Strong Year-Over-Year Growth Amid Revised ... (GuruFocus.com)
Apr-03-25 10:39PM	Preliminary Q1 2025 Rxsight Inc Earnings Call (Thomson Reuters StreetEvents) -37.94%
05:57PM	?RxSight: Navigating Market Headwinds Amid Intensifying Competition (Downgrade) (Seeking Alpha)
03:54PM	RxSight, Inc. (RXST) Q1 2025 Preliminary Results Conference Call (Transcript) (Seeking Alpha)
12:59PM	RxSight Plunges 44% After Slashing 2025 Guidance; Bank of America Downgrades Stock (GuruFocus.com)
07:32AM	RxSight Warns On FY25 Revenue As Premium Cataract Market Faces Headwinds, Stock Plunges (Benzinga)
Apr-02-25 08:00PM	RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance (GlobeNewswire)
Mar-28-25 03:59PM	Baird Q4 2024 Small/Mid Cap Growth Equity Commentary (Seeking Alpha)
Mar-25-25 04:05PM	RxSight, Inc. to Participate in the 24th Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Feb-26-25 02:15AM	RxSight Inc (RXST) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com)
Feb-25-25 05:55PM	RxSight, Inc. (RXST) Misses Q4 Earnings Estimates (Zacks)
04:05PM	RxSight, Inc. Reports Fourth Quarter and Full-Year 2024 Financial Results, Reaffirms 2025 Guidance (GlobeNewswire)
01:36AM	What To Expect From RxSight Inc (RXST) Q4 2024 Earnings (GuruFocus.com)
Feb-11-25 04:10PM	RxSight, Inc. to Report Fourth Quarter Financial Results on February 25, 2025 (GlobeNewswire)
Jan-18-25 07:55AM	RxSight price target lowered to $43 from $66 at Needham (TipRanks)
Jan-12-25 09:30AM	RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2024 Financial and Operational Results and 2025 Guidance (GlobeNewswire)
Jan-02-25 04:05PM	RxSight, Inc. to Present at the J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-20-24 09:43AM	Do You Believe in the Long-Term Growth Potential of RxSight (RXST)? (Insider Monkey) -11.86%
Nov-20-24 12:00PM	RxSight (RXST) Upgraded to Buy: Here's What You Should Know (Zacks)
Nov-08-24 12:02PM	RxSight Inc (RXST) Q3 2024 Earnings Call Highlights: Robust Revenue Growth and Strategic Market ... (GuruFocus.com) -5.59%
Nov-07-24 07:00PM	RxSight, Inc. (RXST) Reports Break-Even Earnings for Q3 (Zacks) -7.09%

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Weinberg Eric	See remarks	Sep 15 '26	Option Exercise	4.34	35,168	152,629	235,516	Sep 16 04:25 PM
Kurtz Ronald M MD	Officer	Sep 02 '26	Proposed Sale	6.96	5,100	35,496		Sep 02 09:45 PM
Wilterding Mark	Officer	Sep 02 '26	Proposed Sale	6.96	7,765	54,044		Sep 02 09:43 PM
Goldshleger Ilya	Officer	Sep 02 '26	Proposed Sale	6.96	2,041	14,205		Sep 02 09:40 PM
Weinberg Eric	Officer	Sep 02 '26	Proposed Sale	6.96	2,041	14,205		Sep 02 09:38 PM
Kurtz Ronald M MD	Chief Medical Officer	Sep 02 '26	Sale	6.96	5,100	35,496	71,775	Sep 02 09:35 PM
Wilterding Mark	Chief Financial Officer	Sep 02 '26	Sale	6.96	7,765	54,044	25,049	Sep 02 09:35 PM
Goldshleger Ilya	Chief Operating Officer	Sep 02 '26	Sale	6.96	2,041	14,205	81,509	Sep 02 09:34 PM
Weinberg Eric	See remarks	Sep 02 '26	Sale	6.96	2,041	14,205	200,348	Sep 02 09:33 PM
RAYMOND W COHEN	Former Director	Aug 18 '26	Proposed Sale	6.37	11,890	75,749		Aug 18 05:45 PM
Goldshleger Ilya	Chief Operating Officer	Apr 17 '26	Option Exercise	4.13	12,489	51,580	78,180	Apr 20 04:19 PM

RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. It also commercializes adjustable intraocular lens (IOL) that is customized after cataract surgery. The company was founded on March 5, 1997 and is headquartered in Aliso Viejo, CA.

Chief Operating OfficerDr. Ilya Goldshleger Ph.D.

Chief Business Development OfficerMr. Eric J. Weinberg

Chief Medical OfficerDr. Ronald M. Kurtz M.D.

Chief Financial OfficerMr. Mark Wilterding

Vice President of Investor RelationsMr. Oliver Moravcevic

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RXST

RxSight Inc

Upgrade your Finviz experience